ASX:EVEFood, Beverage & TobaccoPackaged Foods & Meats
EVE HEALTH GROUP ORD
$0.025
Day Range
$0.025 - $0.025
52 Week Range
$0.017 - $0.044
Volume
50.22K
Avg Volume (10D)
1.66M
Market Cap
$8.74M
Price Chart
Market Statistics
Open$0.025
Previous Close$0.025
Day High$0.025
Day Low$0.025
52 Week High$0.044
52 Week Low$0.017
Valuation
Market Cap8.74M
Shares Outstanding349.58M
Price to Book1.89
Trading Activity
Volume50.22K
Value Traded1.26K
Bid$0.024 × 50,000
Ask$0.025 × 129,550
Performance
1 Day-7.41%
5 Day13.64%
13 Week8.70%
52 Week-37.50%
YTD19.05%
Technical Indicators
RSI (14)61.68
50-Day SMA$0.021
200-Day SMA$0.027
Latest News
Biotechnology
EVE Health Increases Capital Raising to $1.3m with $400,000 Cornerstone Investment
EVE Health Group lifts capital raise to $1.3m with $400k cornerstone, signalling reformulated-drug strategy and new science adviser amid Libbo launch.
1 min read
Biotechnology
EVE Health Group Raises $0.9m to Advance Reformulated Pharmaceutical Pipeline
EVE Health Group raises $0.904m via placement to push reformulated drug delivery pipeline, accelerating IP, regulatory work and licensing talks.
1 min read
Biotechnology
EVE Health Advances Reformulated Drugs Targeting Sexual Health and Cardiovascular Markets
EVE Health advances reformulated ED/PE sprays and Apixaban delivery, expanding its sexual health and cardiovascular pipeline.
2 min read
Biotechnology
EVE Health Group Launches Libbo ED Treatment and Men’s Health Platform
EVE Health (ASX: EVE) launches Libbo ED treatment and men’s health platform, unveiling an end-to-end digital pathway for nationwide access and scalable revenue.
1 min read